Le Swiss Addiction Research Award 2026 a été décerné dans le cadre du Swiss Addiction Research Day, le 13 mars 2026.

Cette année, le conseil d'administration a décidé d'attribuer ce prix aux trois lauréats suivants.

• Dr. phil. Lavinia Baltes
  Effects of legal access versus illegal market cannabis on use and mental health: A randomized controlled trial
• Nathalie Rieser, PHD
  Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A Phase 2 Randomized Clinical Trial 
• Dr. med. Maximilian Meyer
  Relative risks of adverse effects across different opioid agonist treatments—A systematic review and meta-analysis

À l'issue de la cérémonie de remise des prix, les chercheurs récompensés ont eu l'occasion de présenter leurs travaux au public et de donner un aperçu de leurs recherches.

La SSAM félicite chaleureusement les lauréats pour leur réussite et leur souhaite beaucoup de succès et bonne chance pour l'avenir.

As part of the Swiss Addiction Research Day on March 13, 2026, the Swiss Addiction Research Award 2026 was presented.

This year, the committee decided to award it to the following three recipients.

• Dr. phil. Lavinia Baltes
  Effects of legal access versus illegal market cannabis on use and mental health: A randomized controlled trial
• Nathalie Rieser, PHD
  Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A Phase 2 Randomized Clinical Trial 
• Dr. med. Maximilian Meyer
  Relative risks of adverse effects across different opioid agonist treatments - A systematic review and meta-analysis

 Following the ceremony, the awardees had the opportunity to present their research to the audience and share insights into their work.

 SSAM warmly congratulates the recipients on their success and wishes them continued success and all the best for the future.